Syndax Pharmaceuticals Inc
Total Trades
69
Buys
5
Sells
36
Largest Trade
N/A
Insiders
11
Institutional Funds
167
Inst. Value
$1M+
Activist Filings
36
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Metzger Michael A | CEO | SELL | $100K–$500K | 17K | $21.03 | Feb 10, 2026 |
| Goldan Keith A. | CFO | SELL | $50K–$100K | 3K | $21.03 | Feb 10, 2026 |
| Metzger Michael A | CEO | SELL | $100K–$500K | 7K | $20.62 | Feb 6, 2026 |
| Metzger Michael A | CEO | GRANT | N/A | 218K | — | Feb 6, 2026 |
| Goldan Keith A. | CFO | SELL | $15K–$50K | 2K | $20.62 | Feb 6, 2026 |
| Goldan Keith A. | CFO | GRANT | N/A | 52K | — | Feb 6, 2026 |
| Metzger Michael A | CEO | SELL | $1M+ | 157K | $16.41 | Sep 8, 2025 |
| Metzger Michael A | CEO | EXERCISE | $1M+ | 157K | $10.90 | Sep 8, 2025 |
| Goldan Keith A. | CFO | SELL | $1K–$15K | 1K | $9.29 | Jul 18, 2025 |
| Metzger Michael A | CEO | SELL | $50K–$100K | 8K | $9.29 | Jul 18, 2025 |
| Goldan Keith A. | CFO | BUY | N/A | 3K | — | May 19, 2025 |
| Botwood Nicholas A.J. | Head of R&D, CMO | BUY | $100K–$500K | 12K | $8.99 | May 19, 2025 |
| Huber Martin H. Jr. | Director | BUY | $15K–$50K | 5K | $8.99 | May 19, 2025 |
| Katkin Keith | Director | BUY | $50K–$100K | 10K | $9.11 | May 19, 2025 |
| Goldan Keith A. | CFO | BUY | $15K–$50K | 1K | $20.03 | Jun 17, 2024 |
| Morrison Briggs | Director | SELL | $500K+ | 53K | $18.27 | Aug 10, 2023 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 53K | $8.77 | Aug 10, 2023 |
| Meury William | Director | SELL | $1M+ | 83K | $20.46 | Aug 3, 2023 |
| Meury William | Director | EXERCISE | $500K+ | 83K | $8.02 | Aug 3, 2023 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 53K | $8.77 | Jul 11, 2023 |
| Morrison Briggs | Director | SELL | $1M+ | 53K | $20.40 | Jul 11, 2023 |
| Goldan Keith A. | CFO | SELL | $1K–$15K | 577 | $22.31 | Jun 14, 2023 |
| Morrison Briggs | Director | SELL | $1M+ | 53K | $21.18 | Jun 9, 2023 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 53K | $7.66 | Jun 9, 2023 |
| Morrison Briggs | Director | SELL | $1M+ | 53K | $21.41 | May 10, 2023 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 53K | $6.38 | May 10, 2023 |
| Morrison Briggs | Director | SELL | $1M+ | 53K | $19.53 | Apr 12, 2023 |
| Morrison Briggs | Director | EXERCISE | $100K–$500K | 53K | $6.38 | Apr 12, 2023 |
| Morrison Briggs | President | SELL | $1M+ | 53K | $22.53 | Mar 14, 2023 |
| Morrison Briggs | President | EXERCISE | $100K–$500K | 53K | $6.38 | Mar 14, 2023 |
| Ordentlich Peter | Chief Scientific O… | SELL | $500K+ | 25K | $25.84 | Feb 17, 2023 |
| Ordentlich Peter | Chief Scientific O… | EXERCISE | $100K–$500K | 25K | $6.95 | Feb 17, 2023 |
| Metzger Michael A | CEO | EXERCISE | $15K–$50K | 6K | $6.38 | Feb 8, 2023 |
| Metzger Michael A | CEO | SELL | $100K–$500K | 6K | $27.64 | Feb 8, 2023 |
| Morrison Briggs | President | EXERCISE | $100K–$500K | 53K | $6.38 | Feb 8, 2023 |
| Morrison Briggs | President | SELL | $1M+ | 53K | $26.83 | Feb 8, 2023 |
| Ordentlich Peter | Chief Scientific O… | SELL | $1K–$15K | 69 | $28.43 | Feb 3, 2023 |
| Legault Pierre | Director | SELL | $1M+ | 39K | $26.84 | Jan 13, 2023 |
| Legault Pierre | Director | EXERCISE | $100K–$500K | 39K | $11.05 | Jan 13, 2023 |
| Ordentlich Peter | Chief Scientific O… | EXERCISE | $100K–$500K | 25K | $6.38 | Dec 2, 2022 |
| Ordentlich Peter | Chief Scientific O… | SELL | $500K+ | 25K | $25.04 | Dec 2, 2022 |
| Katkin Keith | Director | EXERCISE | $100K–$500K | 30K | $8.20 | Oct 7, 2022 |
| Katkin Keith | Director | SELL | $500K+ | 30K | $25.90 | Oct 7, 2022 |
| Metzger Michael A | CEO | SELL | $100K–$500K | 16K | $25.29 | Oct 7, 2022 |
| Metzger Michael A | CEO | EXERCISE | $100K–$500K | 16K | $8.77 | Oct 7, 2022 |
| Metzger Michael A | CEO | SELL | $500K+ | 34K | $25.02 | Oct 4, 2022 |
| Metzger Michael A | CEO | EXERCISE | $100K–$500K | 34K | $8.77 | Oct 4, 2022 |
| Katkin Keith | Director | EXERCISE | $15K–$50K | 4K | $8.11 | Oct 4, 2022 |
| Katkin Keith | Director | SELL | $100K–$500K | 4K | $25.06 | Oct 4, 2022 |
| Morrison Briggs | President | SELL | $1M+ | 174K | $23.11 | Sep 21, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 167 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Point72 Asset Management, L.P. | 4.9M | $1M+ | SH |
| STATE STREET CORP | 4.6M | $1M+ | SH |
| Soleus Capital Management, L.P. | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $1M+ | SH |
| Ensign Peak Advisors, Inc | 1.6M | $1M+ | SH |
| BNP Paribas Asset Management Holding S.A. | 1.4M | $1M+ | SH |
| MPM BioImpact LLC | 1.3M | $1M+ | SH |
| Aisling Capital Management LP | 1.3M | $1M+ | SH |
| EVENTIDE ASSET MANAGEMENT, LLC | 1.2M | $1M+ | SH |
| Candriam S.C.A. | 925K | $1M+ | SH |
| AQR CAPITAL MANAGEMENT LLC | 911K | $1M+ | SH |
| Palo Alto Investors LP | 795K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 763K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 727K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 724K | $1M+ | SH |
| Prosight Management, LP | 665K | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 643K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 545K | $1M+ | SH |
| Rhenman & Partners Asset Management AB | 487K | $1M+ | SH |
| Brevan Howard Capital Management LP | 484K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G · Feb 9, 2026
5.3%
4.6M shares
SC 13G/A · Jan 30, 2026
7.2%
6.2M shares
Point72 Asset Management, L.P.
SC 13G · Aug 18, 2025
5.0%
4.3M shares
Point72 Asset Management, L.P.
SC 13G/A · Aug 14, 2025
2.7%
2.3M shares
SC 13G/A · Aug 13, 2025
6.5%
5.6M shares
SC 13G/A · May 9, 2025
5.2%
4.5M shares
SC 13G/A · May 7, 2025
2.4%
2.0M shares
SC 13G/A · Apr 17, 2025
7.8%
6.7M shares
Wellington Management Group LLP
SC 13G/A · Mar 7, 2025
0.0%
36K shares
SC 13G/A · Feb 14, 2025
10.0%
8.5M shares
SC 13G · Feb 12, 2025
7.0%
6.0M shares
SC 13G · Feb 5, 2025
6.3%
5.4M shares
Point72 Asset Management, L.P.
SC 13G · Jan 22, 2025
5.0%
4.3M shares
SC 13G/A · Dec 6, 2024
10.3%
8.8M shares
SC 13G/A · Nov 8, 2024
9.7%
8.2M shares
Wellington Management Group LLP
SC 13G/A · Nov 8, 2024
5.9%
5.0M shares
SC 13G/A · Oct 21, 2024
9.7%
8.2M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 18, 2024
4.4%
3.8M shares
Kynam Capital Management, LP 85-3660072
SC 13G · Feb 14, 2024
6.7%
5.7M shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2024
3.3%
2.8M shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2024
4.7%
4.0M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.1%
4.3M shares
SC 13G/A · Jan 25, 2024
8.3%
7.0M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 25, 2024
5.9%
0 shares
Point72 Asset Management, L.P.
SC 13G · Oct 31, 2023
4.5%
3.2M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13G/A · Oct 5, 2023
0 shares
Nantahala Capital Management, LLC
SC 13G/A · Feb 14, 2023
1.4%
976K shares
Avidity Partners Management LP
SC 13G/A · Feb 14, 2023
9.7%
6.7M shares
Frazier Life Sciences Public Fund, L.P.
SC 13G/A · Feb 14, 2023
3.5%
2.4M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2023
1.1%
777K shares
SC 13G/A · Jan 31, 2023
6.4%
4.4M shares
Wellington Management Group LLP
SC 13G · Jan 10, 2023
11.7%
8.0M shares
Access Industries Holdings LLC
SC 13D/A · Mar 4, 2022
4.7%
2.6M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2022
4.7%
2.5M shares
Nantahala Capital Management, LLC
SC 13G · Feb 14, 2022
5.8%
3.1M shares
Avidity Partners Management LP
SC 13G/A · Feb 12, 2022
9.9%
5.2M shares